201 related articles for article (PubMed ID: 29218301)
1. Long-term Outcomes after Salvage Stereotactic Radiosurgery (SRS) following In-Field Failure of Initial SRS for Brain Metastases.
Rana N; Pendyala P; Cleary RK; Luo G; Zhao Z; Chambless LB; Cmelak AJ; Attia A; Stavas MJ
Front Oncol; 2017; 7():279. PubMed ID: 29218301
[TBL] [Abstract][Full Text] [Related]
2. Reirradiation With Stereotactic Radiosurgery After Local or Marginal Recurrence of Brain Metastases From Previous Radiosurgery.
Kowalchuk RO; Niranjan A; Lee CC; Yang HC; Liscak R; Guseynova K; Tripathi M; Kumar N; Peker S; Samanci Y; Hess J; Chiang V; Iorio-Morin C; Mathieu D; Pikis S; Wei Z; Lunsford LD; Trifiletti DM; Sheehan JP
Int J Radiat Oncol Biol Phys; 2022 Mar; 112(3):726-734. PubMed ID: 34644606
[TBL] [Abstract][Full Text] [Related]
3. Fractionated stereotactic radiosurgery for locally recurrent brain metastases after failed stereotactic radiosurgery.
Dincoglan F; Sager O; Demiral S; Gamsiz H; Uysal B; Onal E; Ekmen A; Dirican B; Beyzadeoglu M
Indian J Cancer; 2019; 56(2):151-156. PubMed ID: 31062735
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and Safety of a Second Course of Stereotactic Radiation Therapy for Locally Recurrent Brain Metastases: A Systematic Review.
Lucia F; Touati R; Crainic N; Dissaux G; Pradier O; Bourbonne V; Schick U
Cancers (Basel); 2021 Sep; 13(19):. PubMed ID: 34638412
[TBL] [Abstract][Full Text] [Related]
5. Repeat stereotactic radiosurgery as salvage therapy for locally recurrent brain metastases previously treated with radiosurgery.
McKay WH; McTyre ER; Okoukoni C; Alphonse-Sullivan NK; Ruiz J; Munley MT; Qasem S; Lo HW; Xing F; Laxton AW; Tatter SB; Watabe K; Chan MD
J Neurosurg; 2017 Jul; 127(1):148-156. PubMed ID: 27494815
[TBL] [Abstract][Full Text] [Related]
6. SAFESTEREO: phase II randomized trial to compare stereotactic radiosurgery with fractionated stereotactic radiosurgery for brain metastases.
Crouzen JA; Petoukhova AL; Broekman MLD; Fiocco M; Fisscher UJ; Franssen JH; Gadellaa-van Hooijdonk CGM; Kerkhof M; Kiderlen M; Mast ME; van Rij CM; Nandoe Tewarie R; van de Sande MAE; van der Toorn PPG; Vlasman R; Vos MJ; van der Voort van Zyp NCMG; Wiggenraad RGJ; Wiltink LM; Zindler JD
BMC Cancer; 2023 Mar; 23(1):273. PubMed ID: 36964529
[TBL] [Abstract][Full Text] [Related]
7. Stereotactic reirradiation for local failure of brain metastases following previous radiosurgery: Systematic review and meta-analysis.
Loi M; Caini S; Scoccianti S; Bonomo P; De Vries K; Francolini G; Simontacchi G; Greto D; Desideri I; Meattini I; Nuyttens J; Livi L
Crit Rev Oncol Hematol; 2020 Sep; 153():103043. PubMed ID: 32650217
[TBL] [Abstract][Full Text] [Related]
8. Does size matter? Investigating the optimal planning target volume margin for postoperative stereotactic radiosurgery to resected brain metastases.
Jhaveri J; Chowdhary M; Zhang X; Press RH; Switchenko JM; Ferris MJ; Morgan TM; Roper J; Dhabaan A; Elder E; Eaton BR; Olson JJ; Curran WJ; Shu HG; Crocker IR; Patel KR
J Neurosurg; 2018 Apr; 130(3):797-803. PubMed ID: 29676690
[TBL] [Abstract][Full Text] [Related]
9. Second course of stereotactic radiosurgery for locally recurrent brain metastases: Safety and efficacy.
Moreau J; Khalil T; Dupic G; Chautard E; Lemaire JJ; Magnier F; Dedieu V; Lapeyre M; Verrelle P; Biau J
PLoS One; 2018; 13(4):e0195608. PubMed ID: 29621341
[TBL] [Abstract][Full Text] [Related]
10. Stereotactic radiosurgery for intracranial hemangiopericytomas: a multicenter study.
Cohen-Inbar O; Lee CC; Mousavi SH; Kano H; Mathieu D; Meola A; Nakaji P; Honea N; Johnson M; Abbassy M; Mohammadi AM; Silva D; Yang HC; Grills I; Kondziolka D; Barnett GH; Lunsford LD; Sheehan J
J Neurosurg; 2017 Mar; 126(3):744-754. PubMed ID: 27104850
[TBL] [Abstract][Full Text] [Related]
11. Potential role for LINAC-based stereotactic radiosurgery for the treatment of 5 or more radioresistant melanoma brain metastases.
Frakes JM; Figura NB; Ahmed KA; Juan TH; Patel N; Latifi K; Sarangkasiri S; Strom TJ; Chinnaiyan P; Rao NG; Etame AB
J Neurosurg; 2015 Nov; 123(5):1261-7. PubMed ID: 26140482
[TBL] [Abstract][Full Text] [Related]
12. Time interval from diagnosis to treatment of brain metastases with stereotactic radiosurgery is not associated with radionecrosis or local failure.
Leu J; Akerman M; Mendez C; Lischalk JW; Carpenter T; Ebling D; Haas JA; Witten M; Barbaro M; Duic P; Tessler L; Repka MC
Front Oncol; 2023; 13():1132777. PubMed ID: 37091181
[TBL] [Abstract][Full Text] [Related]
13. Salvage radiosurgery for brain metastases: prognostic factors to consider in patient selection.
Kurtz G; Zadeh G; Gingras-Hill G; Millar BA; Laperriere NJ; Bernstein M; Jiang H; Ménard C; Chung C
Int J Radiat Oncol Biol Phys; 2014 Jan; 88(1):137-42. PubMed ID: 24331660
[TBL] [Abstract][Full Text] [Related]
14. Is upfront stereotactic radiosurgery a rational treatment option for very elderly patients with brain metastases? A retrospective analysis of 106 consecutive patients age 80 years and older.
Yomo S; Hayashi M
BMC Cancer; 2016 Dec; 16(1):948. PubMed ID: 27978813
[TBL] [Abstract][Full Text] [Related]
15. Adverse radiation effect after stereotactic radiosurgery for brain metastases: incidence, time course, and risk factors.
Sneed PK; Mendez J; Vemer-van den Hoek JG; Seymour ZA; Ma L; Molinaro AM; Fogh SE; Nakamura JL; McDermott MW
J Neurosurg; 2015 Aug; 123(2):373-86. PubMed ID: 25978710
[TBL] [Abstract][Full Text] [Related]
16. Repeated in-field radiosurgery for locally recurrent brain metastases: Feasibility, results and survival in a heavily treated patient cohort.
Balermpas P; Stera S; Müller von der Grün J; Loutfi-Krauss B; Forster MT; Wagner M; Keller C; Rödel C; Seifert V; Blanck O; Wolff R
PLoS One; 2018; 13(6):e0198692. PubMed ID: 29874299
[TBL] [Abstract][Full Text] [Related]
17. Stereotactic radiosurgery for brain metastases: analysis of outcome and risk of brain radionecrosis.
Minniti G; Clarke E; Lanzetta G; Osti MF; Trasimeni G; Bozzao A; Romano A; Enrici RM
Radiat Oncol; 2011 May; 6():48. PubMed ID: 21575163
[TBL] [Abstract][Full Text] [Related]
18. Survival was Significantly Better with Surgical/Medical/Radiation Co-interventions in a Single-Institution Practice Audit of Frameless Stereotactic Radiosurgery.
Taggar A; MacKenzie J; Li H; Lau H; Lim G; Nordal R; Hudson A; Khan R; Spencer D; Voroney JP
Cureus; 2016 May; 8(5):e612. PubMed ID: 27335717
[TBL] [Abstract][Full Text] [Related]
19. Impact of 2-staged stereotactic radiosurgery for treatment of brain metastases ≥ 2 cm.
Angelov L; Mohammadi AM; Bennett EE; Abbassy M; Elson P; Chao ST; Montgomery JS; Habboub G; Vogelbaum MA; Suh JH; Murphy ES; Ahluwalia MS; Nagel SJ; Barnett GH
J Neurosurg; 2018 Aug; 129(2):366-382. PubMed ID: 28937324
[TBL] [Abstract][Full Text] [Related]
20. FSRT vs. SRS in Brain Metastases-Differences in Local Control and Radiation Necrosis-A Volumetric Study.
Putz F; Weissmann T; Oft D; Schmidt MA; Roesch J; Siavooshhaghighi H; Filimonova I; Schmitter C; Mengling V; Bert C; Frey B; Lettmaier S; Distel LV; Semrau S; Fietkau R
Front Oncol; 2020; 10():559193. PubMed ID: 33102223
[No Abstract] [Full Text] [Related]
[Next] [New Search]
